Literature DB >> 2988683

Excitatory neurotensin receptors on the smooth muscle of the rat fundus: possible implications in gastric motility.

J P Huidobro-Toro, A Kullak.   

Abstract

Picomolar concentrations of neurotensin caused concentration-dependent contractions of the longitudinal musculature of the fundus of the rat stomach. The EC50 of neurotensin was approximately 1.5 nM. On a molar basis neurotensin was about 5-10 times more potent than 5-hydroxytryptamine (5-HT) and approximately 80 times as active as acetylcholine in producing similar contractions. Studies with structurally related peptides indicated that whereas the carboxy terminal portion of neurotensin was essential for biological activity, a substantial part of its amino terminus end could be removed without affecting its potency. The EC50 for the neurotensin fragment 8-13 was identical to that of neurotensin, however its 1-8 or 1-11 fragments were completely inactive. Tetrodotoxin did not modify the potency of neurotensin or structurally related analogues suggesting that the neurotensin receptor is probably located on the smooth muscle membrane. In addition, the potency of neurotensin in contracting the fundus was not modified by pretreatment with atropine, methysergide or diphenhydramine. Fade to the contractile response of neurotensin was followed by the development of tachyphylaxis; desensitization was concentration-dependent and characterized by a shift in the agonist concentration-response curve to the right and downwards. Desensitization with a priming concentration of neurotensin (approx. EC50) caused a substantial blockade of its excitability. There was cross-desensitization between neurotensin and the contractile activity of neurotensin 8-13 or xenopsin, but not with angiotensin II, bradykinin, substance P, acetylcholine, 5-HT or histamine. Pretreatment of the fundus strip with verapamil 0.3-1 microM antagonized in a concentration-dependent fashion the neurotensin-induced contractions but not the muscular contractions caused by acetylcholine. It is concluded that neurotensin activates a specific excitatory receptor probably located on the cell membrane of the smooth muscles of the rat fundus. In addition, we suggest that this receptor is somehow related to a voltage-dependent calcium channel, sensitive to verapamil.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988683      PMCID: PMC1987055          DOI: 10.1111/j.1476-5381.1985.tb17384.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Apamin blocks certain neurotransmitter-induced increases in potassium permeability.

Authors:  B E Banks; C Brown; G M Burgess; G Burnstock; M Claret; T M Cocks; D H Jenkinson
Journal:  Nature       Date:  1979-11-22       Impact factor: 49.962

2.  The action of neurotensin on single myenteric neurones.

Authors:  J T Williams; Y Katayama; R A North
Journal:  Eur J Pharmacol       Date:  1979-11-16       Impact factor: 4.432

3.  Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry.

Authors:  J M Polak; S N Sullivan; S R Bloom; A M Buchan; P Facer; M R Brown; A G Pearse
Journal:  Nature       Date:  1977-11-10       Impact factor: 49.962

4.  Isolation and structure of a new active peptide "Xenopsin" on the smooth muscle, especially on a strip of fundus from a rat stomach, from the skin of Xenopus laevis.

Authors:  K Araki; S Tachibana; M Uchiyama; T Nakajima; T Yasuhara
Journal:  Chem Pharm Bull (Tokyo)       Date:  1973-12       Impact factor: 1.645

5.  The effect of food ingestion on circulating neurotensin-like immunoreactivity (NTLI) in the human.

Authors:  M L Mashford; G Nilsson; A Rökaeus; S Rosell
Journal:  Acta Physiol Scand       Date:  1978-10

6.  Effects of neurotensin on isolated intestinal smooth muscles.

Authors:  P Kitabgi; P Freychet
Journal:  Eur J Pharmacol       Date:  1978-08-15       Impact factor: 4.432

7.  The stimulatory effects of neurotensin and related peptides in rat stomach strips and guinea-pig atria.

Authors:  R Quirion; D Regoli; F Rioux; S St-Pierre
Journal:  Br J Pharmacol       Date:  1980-01       Impact factor: 8.739

8.  Neurotensin contracts the guinea-pig longitudinal ileal smooth muscle by inducing acetylcholine release.

Authors:  P Kitabgi; P Freychet
Journal:  Eur J Pharmacol       Date:  1979-07-01       Impact factor: 4.432

9.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09

10.  Electrophysiological study of the action of neurotensin on the smooth muscle of the guinea-pig taenia coli.

Authors:  P Kitabgi; G Hamon; M Worcel
Journal:  Eur J Pharmacol       Date:  1979-06       Impact factor: 4.432

View more
  5 in total

1.  Effects of neurotensin on electrical and mechanical properties of smooth muscles in longitudinal and circular layers of the guinea-pig ileum.

Authors:  K Yamanaka; K Kitamura; H Kuriyama
Journal:  Pflugers Arch       Date:  1987-01       Impact factor: 3.657

2.  Species-specific effects of neurotensin on gallbladder contraction in vitro.

Authors:  Y S Guo; P Singh; J R Upp; J C Thompson
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

3.  Involvement of calcium channels in the contractile activity of neurotensin but not acetylcholine: studies with calcium channel blockers and Bay K 8644 on the rat fundus.

Authors:  M V Donoso; J P Huidobro-Toro; A Kullak
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

4.  Gastrointestinal neurotensin receptors: contribution of the aromatic hydroxyl group in position 11 to peptide potency.

Authors:  M V Donoso; J P Huidobro-Toro; S St Pierre
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

5.  Localization of xenopsin and xenopsin precursor fragment immunoreactivities in the skin and gastrointestinal tract of Xenopus laevis.

Authors:  K C Sadler; C L Bevins; J C Kaltenbach
Journal:  Cell Tissue Res       Date:  1992-11       Impact factor: 5.249

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.